Targeting the receptor tyrosine kinase MerTK shows therapeutic value in gastric adenocarcinoma.
Wirsik NM, Chen M, He L, Yasar U, Gaukel J, Quaas A, Nienhüser H, Leugner E, Yuan S, Schleussner N, Jung JO, Plücker JS, Schneider M, Schmidt T.
Wirsik NM, et al. Among authors: plucker js.
Cancer Med. 2024 Apr;13(7):e6866. doi: 10.1002/cam4.6866.
Cancer Med. 2024.
PMID: 38545840
Free PMC article.